Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Alport Syndrome Journey: From Powerless to Empowered - A Patient Perspective. | Glomerular Dis | 2023 | 36814521 | PubTator, text mining | PubMed |
| Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer. | BMC Med | 2023 | 36810084 | PubTator, text mining | PubMed |
| Identification and functional characterization of a novel truncating splicing variant in COL4A5 gene causing X-linked Alport syndrome with astigmatism. | Chin Med J (Engl) | 2023 | 36805600 | PubTator, text mining | PubMed |
| Understanding the Current Landscape of Kidney Disease in Canada to Advance Precision Medicine Guided Personalized Care. | Can J Kidney Health Dis | 2023 | 36798634 | PubTator, text mining | PubMed |
| Molecular pathways that drive diabetic kidney disease. | J Clin Invest | 2023 | 36787250 | PubTator, text mining | PubMed |
| The role of genetic testing in the diagnostic workflow of pediatric patients with kidney diseases: the experience of a single institution. | Hum Genomics | 2023 | 36782285 | PubTator, text mining | PubMed |
| Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration. | Cardiol Cardiovasc Med | 2023 | 36776717 | PubTator, text mining | PubMed |
| A high-impact FN1 variant correlates with fibronectin-mediated glomerulopathy via decreased binding to collagen type IV. | Pathology | 2023 | 36774238 | PubTator, text mining | PubMed |
| Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma. | Cancer Control | 2023 | 36772805 | PubTator, text mining | PubMed |
| Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice. | Int J Mol Sci | 2023 | 36769148 | PubTator, text mining | PubMed |
| Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria. | Pediatr Nephrol | 2023 | 36715773 | PubTator, text mining | PubMed |
| Renal Genetics Clinic: 3-Year Experience in the Cleveland Clinic. | Kidney Med | 2023 | 36712315 | PubTator, text mining | PubMed |
| Transient developmental exposure to low doses of bisphenol F negatively affects neurogliogenesis and olfactory behaviour in adult mice. | Environ Int | 2023 | 36706583 | PubTator, text mining | PubMed |
| The LHX2-OTX2 transcriptional regulatory module controls retinal pigmented epithelium differentiation and underlies genetic risk for age-related macular degeneration. | PLoS Biol | 2023 | 36649236 | PubTator, text mining | PubMed |
| Pathogenic variant detection rate by whole exome sequencing in Thai patients with biopsy-proven focal segmental glomerulosclerosis. | Sci Rep | 2023 | 36646731 | PubTator, text mining | PubMed |
| Progress in genetics of type 2 diabetes and diabetic complications. | J Diabetes Investig | 2023 | 36639962 | PubTator, text mining | PubMed |
| Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management. | Int J Nephrol Renovasc Dis | 2023 | 36636322 | PubTator, text mining | PubMed |
| Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes. | J Clin Invest | 2023 | 36633903 | PubTator, text mining | PubMed |
| Fibrosis resolution in the mouse liver: Role of Mmp12 and potential role of calpain 1/2. | Matrix Biol Plus | 2023 | 36632559 | PubTator, text mining | PubMed |
| Ectopic CH60 mediates HAPLN1-induced cell survival signaling in multiple myeloma. | Life Sci Alliance | 2023 | 36625202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=20